Special Considerations in the Management of HIV-Infected Patients From Minority Communities

  • Authors: Bisola Ojikutu, MD, MPH; Valerie E. Stone, MD, MPH (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/9/18 (What's New)

Summary

  • GRACE trial was a single-arm study of darunavir/ritonavir plus an investigator-selected optimized background regimen in treatment-experienced minorities and women[Smith 2012]
  • Study population included 264 black patients, 96 Latinos, and 65 whites
    • Black patients typically had more advanced disease at study entry and lower adherence on study treatment

Action required